# Boston Scientific announces strategic investment in MiRus LLC
Canonical URL: https://biopharmsignal.com/news/BSX/boston-scientific-announces-strategic-investment-in-mirus-llc
Ticker: BSX
Company: Boston Scientific
Source: Boston Scientific
Published: 2026-05-18 10:30 EST
Original Source URL: https://news.bostonscientific.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-19 10:31 EST — [FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints](https://biopharmsignal.com/news/BSX/fracture-ide-trial-of-the-boston-scientific-seismiqtm-4ce-coronary-intravascular-lithotripsy-catheter-meets-primary-safety-and-effectiveness-endpoints) — Source: Boston Scientific
- 2026-05-18 11:00 EST — [Boston Scientific enters into $2 billion accelerated share repurchase agreement](https://biopharmsignal.com/news/BSX/boston-scientific-enters-into-2-billion-accelerated-share-repurchase-agreement) — Source: Boston Scientific
- 2026-05-18 10:30 EST — [Boston Scientific announces strategic investment in MiRus LLC](https://biopharmsignal.com/news/BSX/boston-scientific-announces-strategic-investment-in-mirus-llc) — Source: Boston Scientific
- 2026-05-04 12:00 EST — [Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results](https://biopharmsignal.com/news/BSX/boston-scientific-announces-participation-in-bernstein-s-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results) — Source: Boston Scientific
- 2026-04-26 17:00 EST — [Data at Heart Rhythm 2026 highlight key Boston Scientific therapies](https://biopharmsignal.com/news/BSX/data-at-heart-rhythm-2026-highlight-key-boston-scientific-therapies) — Source: Boston Scientific
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)